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Abstract
Objective—Nucleotide P2Y2 receptor (P2Y2R) contributes to vascular inflammation by 
increasing vascular cell adhesion molecule (VCAM)-1 expression in endothelial cells (EC), and 
global P2Y2R deficiency prevents fatty streak formation in ApoE−/− mice. Since P2Y2R is 
ubiquitously expressed in vascular cells, we investigated the contribution of endothelial P2Y2R in 
the pathogenesis of atherosclerosis.
Approach and Results—EC-specific P2Y2R-deficient mice were generated by breeding 
VEcadherin5-Cre mice with the P2Y2R “floxed” mice. Endothelial P2Y2R deficiency reduced 
eNOS activity and significantly altered ATP-and UTP-induced vasorelaxation without affecting 
vasodilatory responses to acetylcholine. Telemetric blood pressure and echocardiography 
measurements indicated that EC-specific P2Y2R-deficient mice did not develop hypertension. We 
investigated the role of endothelial P2Y2R in the development of atherosclerotic lesions by 
crossing the EC-specific P2Y2R knockout mice onto an ApoE−/− background and evaluated lesion 
development after feeding a standard chow diet for 25 weeks. Histopathological examination 
demonstrated reduced atherosclerotic lesions in the aortic sinus and entire aorta, decreased 
macrophage infiltration and increased smooth muscle cell and collagen content leading to the 
formation of a subendothelial fibrous cap in EC-specific P2Y2R-deficient ApoE−/− mice. 
Expression and proteolytic activity of matrix metalloproteinase (MMP)-2 was significantly 
reduced in atherosclerotic lesions from EC-specific P2Y2R-deficient ApoE−/− mice. Furthermore, 
EC-specific P2Y2R deficiency inhibited NO production leading to significant increase in SMC 
migration out of aortic explants.
Conclusions—EC-specific P2Y2R-deficiency reduces atherosclerotic burden and promotes 
plaque stability in ApoE−/− mice through impaired macrophage infiltration acting together with 
reduced MMP-2 activity and increased SMC migration.
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Introduction
Endothelial dysfunction and monocyte trans-endothelial migration have been recognized as 
integral components in the initiation and progression of atherosclerosis (1). P2Y2 receptor 
(P2Y2R) activation in vivo enhances neointimal hyperplasia in response to vascular injury 
(2).We recently reported that P2Y2R deficiency prevents fatty streak lesion formation in 
ApoE−/− mice (3). During atherosclerosis, inflammation-induced endothelial barrier 
dysfunction promotes lipoprotein and leukocyte transendothelial flux in the vascular wall 
(4). Extracellular nucleotides acting on P2Y2R regulate the expression of VCAM-1 (5), one 
of the earliest molecular events in the pathogenesis of atherosclerosis (6). These data suggest 
a prominent role for endothelial P2Y2R in the formation of atherosclerotic lesions. However, 
given that this nucleotide receptor is ubiquitously expressed in vascular and blood-derived 
cells (7-10), the relative contribution of endothelial P2Y2R to the pathogenesis of 
atherosclerosis is unclear. We hypothesized that endothelial cell P2Y2R contributes to 
atherosclerosis by conferring an endothelial inflammatory phenotype and promoting 
monocyte infiltration. In the present study, we have generated EC-specific P2Y2R-deficient 
mice on an ApoE−/− background, and characterized the functional contribution of 
endothelial P2Y2R to the development of atherosclerosis.
We determined that in ApoE−/− mice, loss of endothelial cell P2Y2R inhibited the 
progression of atherosclerosis and increased SMC and collagen content in atherosclerotic 
plaques resulting in the formation of a subendothelial fibrous cap. Mechanistically, we 
showed that endothelial P2Y2R deficiency decreased the proteolytic activity of matrix 
metalloproteinase MMP-2 and inhibited NO production leading to significant increase in 
SMC migration. Our findings suggest that targeted inhibition of this nucleotide receptor may 
increase plaque stability.
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Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
Generation of mice with endothelial-specific deletion of P2Y2 receptor
A conditional “floxed” allele of the murine P2Y2R genomic locus was generated by flanking 
the coding region of the P2Y2R gene with loxP sites (Fig. 1A). The P2Y2Rfl/fl mice were 
bred to cadherin 5-Cre (Cre) transgenic mice to generate ECP2Y2R-KO (P2Y2Rfl/fl Cre−/+) 
and control P2Y2Rfl/fl mice. All mice are on a C57BL/6 background. Immunostaining of the 
mouse aorta with antibodies against P2Y2R detected the presence of P2Y2R in both EC and 
SMC in control mice (Fig. 1A). As expected, P2Y2R was expressed in SMC but not in EC in 
the aorta of ECP2Y2R-KO mice (Fig. 1B) whereas, no P2Y2R-positive staining was 
detectable in the aorta of total body P2Y2R knockout mice (Fig. 1B). Western blot analysis 
of lysates from primary EC cultures further confirmed endothelial-specific knockout of the 
P2Y2R (Fig. 1C). In addition, endothelial deletion of P2Y2R did not result in P2Y2R 
deletion from peripheral blood mononuclear cells (Fig. 1C). The ECP2Y2R-KO mice and 
controls were born at the expected Mendelian ratios, and exhibited no obvious 
developmental defects. These data indicated that the P2Y2R is efficiently and specifically 
deleted in the endothelial compartment of ECP2Y2R-KO mice.
Endothelial P2Y2 receptor mediates nucleotide-induced vasodilation
As extracellular nucleotides evoke endothelium-dependent relaxation in the mouse aorta (11) 
we used the ECP2Y2R-KO mice to clarify the role of the P2Y2R in this process. Aortic ring 
constrictions in response to KCl or phenylephrine (PE) were similar between control 
and ECP2Y2R-KO mice (Fig. 2A). Acetylcholine-induced dilations of PE preconstricted 
aortic arch rings were also not significantly different between the two groups (Fig. 3A). 
However, the vasodilatory responses evoked by ATPγS were significantly smaller in 
the ECP2Y2R-KO mice compared to controls (56.5 ± 3.8%, n=8 in controls vs 19.2 ± 10.0%, 
n=5 in ECP2Y2R-KO; Fig. 2B). UTPγS-induced dilations were also significantly impaired 
in the ECP2Y2R-KO aortic rings (80.4 ±8.4%, n=7 in controls vs. 43.6 ± 13.7%, n=5 
in ECP2Y2R-KO; Fig. 2B). Aortic rings in control and ECP2Y2R-KO mice showed complete 
relaxation in response to the P2Y6 receptor agonist UDP (56.5 ± 7.7%, n=9 in controls vs 
66.4 ± 11.5%, n=6 in ECP2Y2R-KO; Fig. 2C). Surprisingly, the P2Y1R agonist ADP, even at 
the highest concentration of 10 μM, dilated neither control nor ECP2Y2R-KO aortic rings 
(Fig. 2C). These data together with the normal vasodilatory responses to Ach demonstrate 
that although the P2Y2-deficiency mice have reduced eNOS activity, this is not sufficient to 
result in systemic arterial hypertension.
Endothelial P2Y2 receptor deletion attenuates eNOS activity in vivo but does not result in 
hypertension
Decreased endothelial nitric oxide synthase (eNOS) activity and nitric oxide (NO) 
production are critical contributors to endothelial dysfunction (12). Interestingly, 
extracellular nucleotides have also been implicated in activation of eNOS, leading to NO 
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generation and vasodilation (13). To explore the mechanisms underlying the reduction of 
endothelium-dependent relaxation in response to nucleotides, we therefore examined the 
effect of ECP2Y2R deletion on eNOS expression and activity. Western blot analysis 
demonstrated a significant (**p<0.01) decrease in eNOS protein levels in the ECP2Y2RKO 
mouse aorta compared to control mice (Fig, 2D). The decreased eNOS protein expression 
correlated with a decrease in plasma nitrate levels in ECP2Y2R-KO mice (Fig. 2E, 
(**p<0.01). A tamoxifen-inducible endothelium-specific P2Y2-deficient mouse (Tie2-
CreERT2 P2Y2Rfl/fl) has been previously reported to develop systemic hypertension (14). 
Blood pressure measurements were thus recorded in our ECP2Y2R-KO mice to determine if 
they also develop hypertension. Radio-telemetry monitoring of blood pressure and heart rate 
showed no difference between ECP2Y2R-KO and control mice (Table 1). Likewise, acute 
blood pressure measurements showed no difference between control and ECP2Y2R-KO mice 
(Table 2). Furthermore, transthoracic echocardiography revealed no significant difference in 
right ventricle diameter or thickness in 5 month-old ECP2Y2R-KO mice relative to control 
mice (Table 3), indicating that these mice did not develop pulmonary hypertension. 
Likewise, left ventricle thickness and diameter were similar in mice of both genotypes. 
Additional parameters of LV function (% fractional shortening, mitral and aortic velocities) 
are also similar between groups (data not shown).The blood pressure data coupled with the 
lack of hypertrophy in both ventricles indicates a lack of systemic hypertension in ECP2Y2R-
KO mice. Together, these data demonstrate that endothelial P2Y2R-deficiency strongly 
reduces eNOS activity in vivo resulting in reduced NO formation which was not 
accompanied by arterial hypertension.
Loss of endothelial P2Y2 receptor reduces atherosclerotic lesions in ApoE−/− mice
Endothelium-dependent vasodilation is involved in atherosclerotic lesion formation (1). To 
examine the contribution of endothelial cell P2Y2R to atherosclerosis, we generated 
atherosclerosis-susceptible mice with endothelial-specific deletion of P2Y2R. To do this, we 
crossed both the P2Y2Rfl/fl mice and the Cad5Cre mice onto an ApoE−/− background to 
generate P2Y2Rfl/fl ApoE−/− Cad5Cre+/− (referred to as ECP2Y2R/ApoE−/−) experimental 
mice and P2Y2Rfl/fl ApoE−/− Cad5Cre−/− controls (referred as to control/ApoE−/−). The 
mice were maintained on a standard chow diet for 25 weeks and analyzed for lipoprotein 
and atherosclerotic lesion characteristics. The two groups of mice did not differ significantly 
in body weight, total plasma cholesterol, or fasting lipoprotein profile (Table 3). En face 
aortic preparations stained with oil-red-O indicate a significant (*p<0.05) reduction in total 
plaque area in ECP2Y2R/ApoE−/− mice as compared to control/ApoE−/− (Fig. 3A). Cross 
sections of aortic sinus specimens stained with Mason's trichrome showed a 40.6% decrease 
in the mean lesion area in the aortic root of ECP2Y2R/ApoE−/− mice compared to control/
ApoE−/− mice (0.320 ±0.019 μm2 , n=5 vs. 0.193 ± 0.009 μm2, n=6 respectively; 
(**p<0.01); Fig. 3A). These results demonstrate that endothelial deletion of P2Y2R reduces 
atherosclerotic plaque burden.
P2Y2 receptor deficiency attenuates inflammation and endothelial barrier dysfunction
We next determined the effect of endothelial cell P2Y2R deficiency on the cellular 
composition of atherosclerotic lesions. Immuno-staining with the anti-macrophage antibody 
Mac-3 revealed that macrophage plaque content in the aortic root lesions of ECP2Y2R/
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ApoE−/− mice was reduced by more than 66% as compared with control mice (***p<0.001) 
Fig. 3B-C). To determine the mechanisms underlying the reduced macrophage plaque 
content in ECP2Y2R/ApoE−/− mice, we examined the effect of endothelial P2Y2R deletion 
on the transmigration of peripheral blood monocytes across endothelial monolayers. As 
shown in Figure 3D, monocyte chemoattractant protein (MCP)-1 increased monocyte 
transmigration across endothelial monolayers from control P2Y2R fl/fl mice whereas loss of 
endothelial P2Y2R (ECP2Y2R-KO mice) significantly impaired monocyte migration. 
Consistent with reduced plaque macrophage content, the percentage of lesion area positive 
for VCAM-1 staining was significantly reduced in the aortic root lesions of ECP2Y2R 
ApoE−/− mice(***p<0.001, Fig. 3B-C). These results suggest that absence of endothelial 
P2Y2R attenuates endothelial barrier dysfunction under pathological conditions. To examine 
the effect of endothelial P2Y2R deletion on vascular integrity in vivo, mice were injected 
with Evans blue dye, and vascular permeability within the aorta was assessed by measuring 
leakage of the dye. As shown in Figure 3E, there was no significant (***p<0.001) difference 
in the amount of dye recovered between control and ECP2Y2R-KO mice on a wild type 
background. In contrast, on an ApoE−/−background, loss of endothelial P2Y2R significantly 
reduced the amount of dye deposited in the aorta compared to control/ApoE−/− mice (Fig. 
3E, (***p<0.001). These results indicate that absence of endothelial P2Y2R attenuates 
endothelial barrier dysfunction under pathological conditions.
Endothelial P2Y2 receptor deficiency promotes fibrous cap formation
The decrease in macrophage content observed in ECP2Y2R ApoE−/− mice suggested that 
there may be an overall increase in SMC or collagen content of the lesions. Total SMC 
content in ECP2Y2R ApoE−/− lesions measured by the SMC marker α-SM-actin represented 
18% of the total lesion area and was 2.2 fold higher that that seen in control/ApoE−/− mice 
(***p<0.001, Fig. 4B-C). Cap-like structures were observed in ECP2Y2R/ApoE−/− 
atherosclerotic lesions but not in control/ApoE−/− lesions (Fig. 4A). The increase in collagen 
content observed in ECP2Y2R/ApoE−/− mouse plaques correlated with a dramatic increase in 
the cross-section area stained with Masson's Trichrome (53.4%± 3.6% as compared to 23.6 
± 2.0% in controls; ***p<0.001; Fig. 4A-C). Our results strongly suggest that deletion of 
endothelial P2Y2R shifts plaque phenotype from an inflammatory status to a more stable 
plaque characterized by an abundance of SMC and fibrous connective tissue.
Endothelial deletion of P2Y2R decreases MMP-2 activity in atherosclerotic lesions
MMPs are thought to enhance migration and proliferation of SMC during early stages of the 
atherosclerotic process while in advanced plaques, inflammation-derived proteolytic activity 
may weaken the plaque. As atherosclerotic lesions in ECP2Y2R/ApoE−/− mice exhibited 
increased SMC and collagen content compared to lesions in ApoE−/− mice, we examined 
whether endothelial P2Y2R deficiency alter MMP proteolytic activity in atherosclerotic 
lesions of 25 week old mice. Gelatin zymography analysis of protein extracts from the aortic 
arch revealed a significant (*p < 0.05) decrease in MMP-2 activity in ECP2Y2R/ApoE−/− 
mice compared to control/ApoE−/− (Fig. 5A). This reduction in MMP-2 activity was 
paralleled by a decrease in MMP-2 mRNA expression as demonstrated by qPCR (***p < 
0.001; Fig. 5B). Pro-MMP-9 expression in the lesions was similar between control/ApoE−/− 
and ECP2Y2R/ApoE mice. However, MMP-9 proteolytic activity was not detected in the 
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lesions. Protein and mRNA levels of tissue inhibitor of metalloproteinase (TIMP)-2 were 
significantly (**p < 0.01) higher in the aortic arch of ECP2Y2R/ApoE−/− mice whereas 
TIMP-1 expression levels were similar between the two genotypes (Fig. 5B-C). These data 
indicate that endothelial P2Y2R deficiency inhibits MMP-2 activity in the atherosclerotic 
lesions in ApoE−/− mice.
Endothelial deletion of P2Y2R increases SMC migration ex vivo
To explore the mechanisms underlying the increased accumulation of SMC in ECP2Y2R 
ApoE−/− lesions, we examined the effect endothelial P2Y2R deletion on migration of SMC 
out of aortic explants. NO derived from endothelial cells has been shown to inhibit SMC 
migration and proliferation (15-16). We, therefore, examined if SMC migration is altered 
in ECP2Y2R-KO mice that exhibit reduced eNOS levels. We first established that aortic 
explants from ECP2Y2R-KO mice released significantly less NO in the culture medium than 
explanted aortas from control mice (Fig. 6A, **p < 0.01, n=7). About 90% of aortic explants 
from ECP2Y2R-KO mice exhibit migrating SMC at day 10 compared to only 65% in control/
ApoE−/− (**p < 0.01), Fig. 6B). At day 7, an average of 15± 4.3 (p<0.05, n=7) migrated 
cells per explant (p<0.05, n=7) was observed in ECP2Y2R/ApoE−/− mice compared to 6± 2.2 
migrated cells per explant (n=15) in control mice. Immunofluorescence staining indicated 
that the migrated cells expressed the SMC marker desmin and were negative for the 
endothelial cell marker CD31 (not shown). Notably, addition of the nitric oxide synthase 
inhibitor L-NAME (10 mmol/L) to the culture media equally enhanced SMC migration out 
of the explants from the control mice such that there was no difference in the migration of 
P2Y2R and control cells (Fig. 6C). These data indicate that loss of endothelial P2Y2R 
enhances SMC migration through decreased NO release thereby contributing to SMC 
accumulation in ECP2Y2R-KO lesions.
Discussion
To examine the contribution of endothelial P2Y2 receptor (P2Y2R) to the pathogenesis of 
atherosclerosis, we generated mice harboring an EC-specific P2Y2R deletion mice on an 
ApoE−/− background. We demonstrated that on the ApoE−/− background EC-specific P2Y2R 
deficiency attenuates endothelial barrier dysfunction, decreases both inflammation and the 
burden of atherosclerosis. Most notably, EC-specific P2Y2R deficiency increases SMC and 
collagen plaque content leading to the formation of sub-endothelial fibrous cap. 
Mechanistically, endothelial P2Y2R-deficiency decreases VCAM-1 expression resulting in 
decreased recruitment of macrophages into the atherosclerotic plaques. Conversely, 
endothelial P2Y2R deficiency also decreases eNOS activity resulting in reduced NO 
production and increased SMC migration. Futhermore, we demonstrated that EC-specific 
P2Y2R deficiency reduced MMP-2 proteolytic activity in atherosclerotic lesions in ApoE−/− 
mice. Thus, our data suggest that therapies directed against EC P2Y2R might decrease 
plaque burden and increase plaque stability.
Extracellular nucleotides are maintained at very low levels due to rapid hydrolysis by 
ectonucleotidases (17). Under physiological conditions ATP released from the endothelium 
may exert a potent regulation on vascular tone (18). Aortic rings from P2Y2 receptor 
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knockout mice (P2Y2R−/−) exhibit impaired vasorelaxation in response to nucleotides (19). 
In these mice, it was reported that ATP-induced dilation is mediated by both P2Y1 and P2Y2 
receptors, while UTP-dependent vasodilation is attributed mostly to the P2Y6R. As these 
P2Y2R−/− mice lack the P2Y2R in both endothelial and smooth muscle cells, in the present 
study we sought to clarify the role of endothelial P2Y2R in endothelium-dependent 
relaxation. Using mice with EC-specific deletion of P2Y2R, we demonstrated that the 
vasodilatory effects of ATP and UTP are mainly mediated by endothelial P2Y2R. In 
addition, we established that P2Y1R is not involved in ATP-induced relaxation since ADP 
even at high concentrations could not elicit relaxation of aortic rings in either control 
or ECP2Y2R-KO mice. Furthermore, our results showed that Ach-induced dilation of PE pre-
constricted aortic rings were similar between control and ECP2Y2R-KO mice, indicating that 
loss of endothelial P2Y2R does not result in generalized endothelial dysfunction. Although 
nucleotide-mediated vasomotor responses may vary among different vascular beds (20), our 
findings reveal that endothelial P2Y2R is the main receptor that mediates ATP -and UTP-
dependent vasodilation in the aorta.
Impaired endothelium-dependent vasodilation is associated with the development of 
essential hypertension in humans and mice (20-21). P2Y2R−/− mice were found to develop 
salt-resistant hypertension (22), and P2Y2R activation decreases blood pressure in mice (23). 
Furthermore, a tamoxifen-induced endothelium-specific P2Y2-deficient mouse (Tie2-
CreERT2 P2Y2Rfl/fl) was reported to develop spontaneous hypertension (14). Interestingly, 
our ECP2Y2R-KO did not develop hypertension as assessed by either acute or chronic 
measurements of blood pressure and the lack of hypertrophy in either ventricle. We 
demonstrated that endothelial deletion of P2Y2R using cadherin 5-Cre transgenic mice did 
not result in P2Y2R deletion from peripheral blood mononuclear cells. As Tie2-Cre–
mediated deletion of P2Y2R may also lead to excision from P2Y2R bone marrow derived 
cells, together these data suggest that it may be the loss of P2Y2R from bone marrow derived 
cells that accounts for the development of hypertension in P2Y2R−/− mice. Heterologous 
bone marrow transplants into global P2Y2R−/− mice will be required to resolve this issue.
Although our data suggest that loss of endothelial P2Y2R does not result in systemic 
hypertension, functional impairment of the vascular endothelium is found in most forms of 
cardiovascular diseases including atherosclerosis (1). Endothelial dysfunction is associated 
with increased leukocyte transmigration and increasd permeability of endothelium (1, 24). 
Significant amounts of extracellular ATP may locally accumulate in the vasculature during 
traumatic and pathological events (7) and P2Y2R activation has been shown to induce a 
transient increase in venular permeability to albumin (25), suggesting that the P2Y2R may 
play a role in regulating vascular permeability. Accordingly, we found that EC-specific 
P2Y2R deletion attenuated endothelial barrier dysfunction that occurs in ApoE−/− mice as 
evidenced by decreased Evans blue dye accumulation observed in ECP2Y2R/ApoE−/− mice 
compared to control/ApoE−/− mice. In addition, monocyte transmigration across endothelial 
monolayers isolated from ECP2Y2R-KO mice was significantly decreased compared to 
endothelial cells isolated from control mice. These data strongly imply that the decreased 
monocyte content of atherosclerotic lesions in ECP2Y2R/ApoE−/− mice is likely to be due at 
least in part to impaired monocyte transmigration. We have also shown that loss of P2Y2R 
attenuates VCAM-1 expression in endothelial cells (3) suggesting that decreased binding of 
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the monocytes likely also contributes to the decreased monocytes seen in atherosclerotic 
plaques of ECP2Y2R/ApoE−/− mice. Significantly less VCAM-1-positive areas were also 
observed in atherosclerotic lesions in ECP2Y2R/ApoE−/− mice. We recently reported that 
global P2Y2R deficiency prevents fatty streak lesion formation in ApoE−/− mice (3). 
Altogether, these data indicate a major effect of endothelial P2Y2R deletion may be to 
reduce vascular inflammation.
The formation of fibrous caps in atherosclerotic lesions of ECP2Y2R/ApoE−/− mice was a 
major finding of the present study. SMC accumulation could be the result of both increased 
matrix metalloproteinase activity and migration of vascular SMC. However, gelatin 
zymography showed significantly lower activity of MMP-2 in the lesions of 25 week-
old ECP2Y2R/ApoE−/− mice and no MMP-9 activity was detected at this time point. The 
decrease in MMP-2 activity was paralleled by a significant increase in TIMP-2 protein and 
mRNA levels in the plaques. Although these data do not rule out a possible transient 
increase in MMP activity at an earlier stage of plaque development, they suggest that in 
mature plaques decreased MMP2 activity in ECP2Y2R/ApoE−/− mice could have a beneficial 
effect by increasing plaque stability. Despite the decreased MMP activity, we observed a 
significant increase in SMC migration of aortic segments from ECP2Y2R/ApoE−/− mice 
(Figure 6B) suggesting that the increased SMC content of the fibrous plaque may be due to 
increased SMC migration. We postulate that this occurs as a consequence of decreased 
endothelial NO. In support of this, studies have shown that transfection of eNOS gene into 
SMC can effectively inhibit their migration in response to chemotactic agents (26). 
Futhermore, the difference in SMC migration between explants derived from the control 
and ECP2Y2R/ApoE−/− mice was abrogated in the presence of a specific eNOS inhibitor (L-
NAME, Figure 6C). Together these findings suggest that EC-specific deletion of P2Y2R may 
be contributing to plaque stability by not only increasing its SMC content but also by 
downregulating MMP-2 activity.
In conclusion, this study shows that decreased VCAM-1 expression leading to impaired 
macrophage infiltration acting together with MMP-2 activity and increased SMC migration 
resulting from diminished eNOS activity could explain the beneficial effects on plaque 
stabilization observed in ECP2Y2R ApoE−/− mice. Thus, targeted inhibition of P2Y2R-
mediated signals in endothelial cells may be a viable approach to decrease plaque burden 
and improve plaque stability.
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Nonstandard Abbreviations
ATP Adenosine 5-triphosphate
ADP Adenosine diphosphate
ApoE−/− Applipoprotein E null
EC Endothelial cells
L-NAME Nω-Nitro-L-arginine methyl ester hydrochloride
PBMC Peripheral blood mononuclear cells
MMP Matrix metalloproteinases
SMC Smooth muscle cells
SMA Smooth muscle actin
TIMP Tissue inhibitor of matrix metalloproteinase
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Highlights
• Endothelial cell-specific deletion of P2Y2 receptor reduces eNOS activity and 
reveals a major role for P2Y2 receptor in nucleotide-mediated vasodilation.
• Endothelial cell-specific deletion of P2Y2 receptor attenuates vascular 
permeability in ApoE-null mice.
• Endothelial cell-specific deletion of P2Y2 receptor decreases 
metalloproteinase activity and smooth muscle migration in atherosclerotic 
lesions.
• Endothelial cell-specific deletion of P2Y2 receptor promotes fibrous cap 
formation in ApoE-null mice.
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Figure 1. 
Generation of ECP2Y2R-KO mice. A. The wild type mouse P2Y2R locus is indicated in the 
upper panel. The positions of the 5’, 3’ and loxP homology arms used to generating the 
targeting vector are indicated. Exons 2 and 3 of the gene are indicate by blue boxes. The 
positions of primers used for genotyping are also indicated. Schematics of the targeted locus, 
the FLPe deleted locus, in which the neo cassette was removed and the final cre deleted or 
knockout locus are also shown. Cre-mediated deletion results in excision of the entire coding 
region of the P2Y2R gene. B, Immunostaining of P2Y2R in cross sections of aortic vessels 
in control, ECP2Y2R-KO and P2Y2R−/− (total body P2Y2R knock out) mice. P2Y2R is 
expressed in both EC and SMC in aorta of control mice whereas in ECP2Y2R-KO mice 
expression was only detected in SMC. P2Y2R staining was absent from EC and SMC in the 
aorta of P2Y2R−/−mice. Scale bar represents 50μm. C, Western blot analysis of P2Y2R 
expression in primary cultured EC, SMC and PBMC from control and ECP2Y2R-KO mice. 
Data shown are representative of experiments performed from 4 mice for each genotype.
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Figure 2. 
Endothelial deletion of P2Y2R results in significant decrease in nucleotide- induced 
vasodilation and eNOS activity. ATPγS- or UTPγS-induced dilations are significantly 
decreased in the aortic rings from ECP2Y2R-KO mice. Phenylephrine (PE)- and 70 mM 
KCl-induced contractions and Ach-induced dilations in PE pre-constricted aortic rings from 
control and ECP2Y2R- KO mice are shown in A. Sample traces and concentration-response 
curves for ATPγS, UTPγS and ADP, UDP induced effects in PE pre-constricted aortic rings 
are shown in B and C, respectively. *p<0.05, **p<0.01 and ***p<0.001. D, Western blot 
analysis of total eNOS protein and phosphorylated eNOS (serine 1176) in aortic arch lysates 
from control and ECP2Y2R-KO. Densitometry analysis are shown in graphs (n= 7, **p < 
0.01). E, Plasma nitrate and nitrite levels in control (n=10) and ECP2Y2R-KO mice (n= 11). 
Data are mean ± SEM; ****p<0,0001 by 2-tailed Student's t test.
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Figure 3. 
Endothelial cell-specific deletion of P2Y2R reduces atherosclerosis, inflammation and 
endothelial barrier dysfunction in ApoE−/− mice. A, Analysis of atherosclerotic lesions 
in ECP2Y2R ApoE−/− and control ApoE−/− mice fed standard chow diet for 25 weeks. Left 
panel shows representative photomicrographs of Oil red O-stained aortas collected between 
the subclavian and iliac branches and quantitative computer- assisted image analysis of lipid 
deposition in the entire aorta. Data represent the percentage surface area of the aorta 
occupied by atherosclerotic lesions in control (n=14) and ECP2Y2R/ApoE−/− mice (n=14). 
****p<0.0001. Right panel shows representative images of cross sections of aortic sinus 
from ECP2Y2R/ApoE−/− and control/ApoE−/− mice stained with Masson's trichrome. Scale 
bar represents 250 μm. The adjacent graphs shows the mean ±SEM lesion area measured in 
5 sections for each of 14 animals. The lesion area in the aortic sinus was determined by 
computer-assisted image analysis. The yellow lines delineate the lesions. **p < 0.01. B, 
Representative images of immunohistological staining of atherosclerotic lesions in the aortic 
sinus stained with the anti-macrophage Mac-3 antibody or VCAM-1 as indicated. Scale bar 
represents 50 μm and the scale bar in inset represents 250 μm. Morphometric analysis of the 
stained areas are indicated in panel C. Data are the mean ±SEM of the percentage staining of 
the total plaque area in 5 consecutive sections in 5 mice for each genotype. ***p<0.001. D, 
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Monocyte transmigration across endothelial cell monolayers from control and ECP2Y2R-KO 
mice. EC were grown on transwell membrane with monocytes from wild-type added to the 
top chamber and MCP-1 to the bottom. Transmigrated monocytes were counted and 
normalized to the non-treated condition (without MCP-1). ****p< 0.0001. E, Mice were 
injected with Evans blue dye and leakage of the dye into the aortas was quantified after 
extracting the dye and measuring absorbance at 620 nm. Values were normalized to the dry 
weight of the aorta. Data represent mean ±SEM; (n= 5). ***p < 0.001.
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Figure 4. 
Endothelial cell-specific deletion of P2Y2R promotes fibrous cap formation. A, Masson's 
trichrome showing collagen fibers (blue) and immunohistochemical staining for αSM-actin 
(B) in atherosclerotic lesions of ApoE−/− and ECP2Y2R/ApoE−/− mice. The areas occupied 
by α-SM actin staining or collagen were expressed as percentage of total cross-section 
lesion area. Scale bar represents 50 μm and the scale bar in inset represents 250 μm. (C). A 
continuous fibrous cap can be observed in the lesions of ECP2Y2R/ApoE−/− mice but was 
notably absent in lesions from ApoE−/− mice. Data represent mean ±SEM; ***p<0.001, 
****p<0.0001. (n=5 mice for each genotype).
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Figure 5. 
Endothelial deletion of P2Y2R increases MMP-2 activity in atherosclerotic lesions. A, 
Reduced gelatinolytic activity in 25 week-old ECP2Y2R/ApoE−/− mice. Representative 
zymogram demonstrating a significantly reduced MMP-2 activity (****p<0.0001) in 
the ECP2Y2R/ApoE−/− aortic arch compared to control/ApoE−/−. Data represent mean 
±SEM; (n=9 mice per group); ****p <0.0001. There was no significant differences in pro-
MMP-9 activity between control/ApoE−/− and ECP2Y2R/ApoE−/− mice. This decrease in 
MMP-2 activity was correlated with decreased MMP-2 mRNA levels (**p<0.01, n=5) as 
shown by qPCR (B).C, Western blot analysis shows a significant increase in TIMP-2 protein 
levels in ECP2Y2R/ApoE−/− mice compared to control/ApoE−/− (n=5, **p< 0.01) whereas 
TIMP-1 protein levels were unchanged.
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Figure 6. 
Endothelial deletion of P2Y2R decreases NO production but increases SMC migration from 
aortic explants. A, NO release from the aortic explants from control and ECP2Y2R-KO mice 
(n=7 for each genotype) was measured by determining the production of nitrite in the 
cultured medium after 4 days. Data represent mean ±SEM, **p < 0.01. B, Cell migration 
was expressed as percent of explants exhibiting at least one SMC outside the explant. SMC 
migration was significantly increased in explants from ECP2Y2R/ApoE−/− mice as compared 
to control/ApoE−/− mice (n=10 mice per group. *p < 0.05, **p < 0.01,***p < 0.001 by 2-
tailed Student's t test. C, SMC migration out of aortic explants in presence of the eNOS 
inhibitor L-NAME (10 mmol/L) was similar in control and ECP2Y2R-KO mice.
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Table 1
Radiotelemetry blood pressure measurements
Control (n=5) ECP2Y2R-KO (n=5)
Baseline SPB (mmHg)
Night time 144.92±12.51 143.06±11.50
Daytime 93.28±13.06 88.40±13.53
Heart rate (beats/min)
Night time 579.04±74.70 585.10±56.67
Daytime 402.68±57.38 374.03±47.14
Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Xingjuan et al. Page 20
Table 2
Acute blood pressure measurements
Control (n=12) ECP2Y2R-KO (n=12)
Baseline SPB (mmHg) 82.84±4.05 82.43±4.50
Heart rate (beat/min) 524.01±33.94 520.11±95.13
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Table 3
Echocardiography data in conscious mice
Mice Weight (g) RVW (mm) RVD (mm) LVD (mm) LVW (mm)
Control 30.25±2.63 0.36±0.09 1.84±0.21 4.07±0.23 0.64±0.09
ECP2Y2R-KO 30.58±3.09 0.36±0.09 1.72±0.23 4.15±0.45 0.63±0.08
P<0.05 versus RVW, Right ventricle wall thickness; RVD, Right ventricle chamber diameter; LVD, Left ventricle chamber diameter; LVW, Left 
ventricle posterior wall thickness.
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Table 4
Body weight and plasma lipid profile of 25-week old ECP2Y2R/ApoE−/− and control/ApoE−/−
Control/ApoE−/− (n=12) ECP2Y2R/ApoE−/− (n=12)
Body weight (g) 34.4± 4 33.7± 5
Total cholesterol (mg/dl) 489± 28 481± 22
Triglycerides (mg/dl) 68± 7 67± 6
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